Digestive System TRIZ Cases

Anti-progastrin antibodies neutralize progastrin activity to overcome chemotherapeutic efflux resistance and prevent tumor recurrence in liver cancer therapy.

Protein biomarker analysis from lower digestive tract biopsies resolves diagnostic ambiguity between ulcerative colitis and Crohn's disease.

Vδ1+ γδ T cells expressing natural cytotoxicity receptors overcome ULBP1 down-regulation in hematological tumors.

Plant-derived ovatodiolide and zerumbone suppress inflammatory cytokines, addressing limited efficacy of conventional medications.

Specific probiotic strains activate TLR2 receptors to increase occludin expression and improve intestinal barrier integrity.

Periodic bremelanotide dosing treats female sexual dysfunction while maintaining systolic and diastolic blood pressures below 130 and 80 mmHg.

Tridentate SAAC ligands stabilize technetium and rhenium complexes, resolving stability issues while enabling rapid renal clearance.

Gamma-ketoaldehyde scavengers remove toxic oxidized lipids to attenuate hepatic fibrosis without the side effects of existing therapeutics.

Anti-Adrenomedullin antibodies resolve kidney damage trade-offs by blocking ADM signaling to treat congestion without diuretic side effects.

Uniform polymeric coatings mask active ingredient taste while enabling controlled gastrointestinal release, resolving solvent use and process duration issues.

Calcimimetic compounds bind to calcium-sensing receptors to induce conformational changes that modulate intracellular calcium levels.

Vixarelimab blocks the OSM/OSMRβ pathway to achieve clinical remission in moderate to severe ulcerative colitis patients without serious side effects.

Anion and metal ion precipitation forms gigaseals without premature salt buildup, enabling accurate Ca2+-activated channel measurements.

Low MHC-I neonatal stromal cells resolve adult tissue scarcity and heterogeneity, ensuring scalable manufacturing and reproducible clinical efficacy.

Glycine-conjugated beta-MCA derivatives reduce bile acid pool size and hydrophobicity, addressing limited therapeutic options in cholestasis.

Novel FXR agonists address the lack of effective therapeutic options by reducing liver fat and fibrosis in non-alcoholic steatohepatitis.

PEGylated human antibodies reduce blood clearance and immunogenicity while maintaining cross-reactivity.

Extracting five core ingredients from traditional herbs reduces manufacturing complexity and side effects while elevating albumin levels.

A dry composition dissolvable in water containing glucose, sugar alcohols, and mucoprotectants maintains osmolarity above 170 mOsm/L.

Autologous adipose stem cells expand in vitro then migrate to the liver to restore function, avoiding irreversible damage from chronic disease.

Peripheral blood lymphocytes co-cultured with aged mesenchymal stem cells reverse aging markers and enhance proliferation.

M1 and M2 iPSC-derived macrophages reduce fibrogenic gene expression in chronic liver disease.

MMP inhibitor mediates HCV treatment by blocking TNF-alpha signaling, reducing liver damage and lowering enzyme levels.

Coupling oxazolidin[2,3-c]morpholine with a Grignard reagent eliminates toxic reagents and shortens the synthesis pathway for industrial production.

Processed granular wheat middlings carrier improves flow characteristics, eliminating surge flow and bridge over issues during conveyance.

Cell-based vaccines induce antibodies to impair methanogens, reducing methane emissions by 17% without daily dosage control.

Small molecule compounds inhibit Factor D protease activity, attenuating inflammatory responses and cellular damage in age-related macular degeneration.

Co-seeding muscle cell precursors and fibroblasts into tissue scaffolds improves cell engraftment uniformity.

Sugar cane polysaccharide fraction activates Peyer's patches to enhance cytokine production, addressing limited immune modulators.

High-affinity antibody inhibits sclerostin to promote osteogenesis, overcoming bisphosphonate limitations.

Agents inducing LC3-associated phagocytosis reprogram monocytes to reduce hepatic inflammation.

A feed supplement combining humic acids with zinc and copper compounds to promote microbiota balance in piglets.

A pharmaceutical composition uses beta-cyclodextrin to enhance water solubility of a specific active ingredient.

MBX-8025 reduces alkaline phosphatase and gamma-glutamyl transpeptidase levels, addressing cholestasis symptoms without requiring transplantation.

A triglyceride matrix protects sodium butyrate in an oral formulation, enabling controlled release in the intestine to replace inconvenient enemas.

A deprotection and cyclization process produces delmopinol using mild reagents.

Fusion proteins attach to exosomes to cross the blood-brain barrier while maintaining cell-type specificity.

Formula I compounds activate TRβ receptors to reverse established fibrosis, addressing the irreversibility limitation of current antifibrotic therapies.

Plasma fractions stimulate hepatocyte proliferation, addressing organ scarcity by enabling self-service regeneration.

A bioadhesive oral composition forms a protective alginate raft on gastric juices to prevent acid reflux.

Segmented formulations resolve contradictions between breed-specific nutrition and production complexity by maintaining bone density and antioxidant status.

A Prodefensin-A6 biomarker assay detects colorectal cancer in biological samples.

Combines digestive and respiratory herbs to address inadequate dietary intake and growth issues in children with normal clinical profiles.

Increasing rumen oxidation-reduction potential with oxidizing agents inhibits methanogenesis while maintaining digestibility and avoiding toxic residues.

RGD-modified alginate microbeads co-encapsulate hepatocytes and mesenchymal stromal cells to enhance long-term viability.

Specific amino acid mutations hyperactivate human acidic chitinase, resolving the low activity versus pH stability trade-off for medical applications.

A hydrogel fiber capsule encapsulates mesenchymal stem cells to enable targeted tissue repair.